The shortage of neurosurgical materials in the United States will continue until 2026.
The United States continues to experience a shortage of sterile materials used in neurosurgery, a situation that may persist until the end of 2026. Medical institutions are advised to use their supplies sparingly and reserve them for critical surgeries.
Salus
The United States continues to face a shortage of sterile wipes, sponges, and strips used in neurosurgery—a situation that, according to the Food and Drug Administration (FDA), may persist until the end of 2026.
Neurosurgical tampons, sponges, and strips have been added to the list of medical devices in short supply. These materials are essential during neurosurgical and microsurgical procedures for absorbing fluids and protecting sensitive tissues.
In March, Medline Industries recalled neurosurgical tampons from its Neuro Sponge product line due to elevated endotoxin levels. The timeline for resuming supply of these products remains uncertain.
Use of the affected products may lead to health complications requiring medical or surgical intervention, including fever, inflammation, low blood pressure, and nausea.
The FDA is working with other manufacturers and healthcare facilities to monitor inventory and seek solutions to minimize the negative impact of the shortage on patients.
Healthcare institutions are advised to use these materials sparingly and reserve them for the most critical cases, such as brain surgeries and procedures where alternative products cannot be used.